Επεμβατική Καρδιολογία

Περιλήψεις – Παρουσιάσεις

  1. 2012 – Ziakas A, Papaioannou GI, Toutouzas K, et al. Use of radial approach for coronary procedures in Greece. J Invasive Cardiol 2013:24(9):6.
  2. 2006 – Athar H, Mamkin I, Shah AR, Papaioannou GI, et al. Decreased in-hospital mortality of patients with ST-segment elevation myocardial infarction treated with pharmacoinvasive therapy: Is benefit of facilitated PCI limited to prolonged door-to-balloon time? Circulation 2006;114:II-347.
  3. 2005 – Papaioannou GI, Athar H, Dada MR, et al. Facilitated percutaneous coronary intervention is the optimal treatment strategy in patients with anterior myocardial infarction presenting to community hospitals within three hours of symptom onset. ESC Congress 2005:P460.
  4. 2005 – Papaioannou GI, Athar H, Dada MR, et al. Predictors of contrast nephropathy in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. ESC Congress 2005:2699.
  5. 2005 – Deliargyris EN, Papaioannou GI, Tsaousis GS, et al. Direct thrombin inhibition with bivalirudin results in improved myocardial perfusion compared with heparin during primary or rescue angioplasty. AICT 2005.
  6. 2005 – Tsaousis GS, Papaioannou GI, Lambrou SG et al. Closure of intracardiac communications in adults with cryptogenic stroke: the necessity of a multidisciplinary approach. AICT 2005.
  7. 2005 – Lundbye J, Elkoustaf R, Papaioannou GI, et al. Independent predictors of ST-segment resolution in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv 2005;65:155.
  8. 2005 – Athar H, Papaioannou GI, Dada MR, et al. Do women with ST-segment elevation myocardial infarction have a higher in-hospital mortality if transferred for percutaneous coronary intervention? The role of facilitated intervention. Catheter Cardiovasc Interv 2005;65:108.
  9. 2005 – Athar H, Papaioannou GI, Dada MR, et al. Anemia and need for transfusion predict contrast nephropathy in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Catheter Cardiovasc Interv 2005;65:85.
  10. 2005 – Papaioannou GI, Athar H, Patel SB, et al. Does facilitated percutaneous coronary intervention extend optimal door-to-balloon time in patients with ST-segment elevation myocardial infarction presenting in community hospitals? J Am Coll Cardiol 2005;45(Suppl A):193A.
  11. 2005 – Ausef AH, Ahlberg AW, Papaioannou GI, et al. Stress Tc-99m sestamibi ECG-gated SPECT is effective for risk stratification of patients with left ventricular systolic dysfunction and suspected CAD. J Nucl Cardiol 2005;S55.
  12. 2004 – Papaioannou GI,Dada MR, Patel SB, et al. Improved outcomes among patients with ST-Segment elevation myocardial infarction presenting to community hospitals and treated with facilitated percutaneous coronary intervention with antecedent bolus fibrinolytic and/or glycoprotein IIb/IIIa therapy. Circulation 2004;110(Suppl III):537.
  13. 2004 – Ahmed MH, Lundbye JB, Sadiq I, Papaioannou GI et al. Anemia is an independent predictor of in-hospital mortality and late adverse clinical outcomes in patients undergoing percutaneous coronary intervention. Circulation 2004;110(Suppl III):493.
  14. 2004 – Papaioannou GI, Lundbye J, Sadiq I, et al. Baseline anemia predicts adverse in-hospital outcomes in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. Am J Cardiol 2004;94(Suppl):240E.
  15. 2004 – Sadiq I, Athar H, Papaioannou GI, et al. Management of in-stent restenosis – Intracoronary brachytherapy vs drug-eluting stents. Am J Cardiol 2004;94(Suppl):147E
  16. 2004 – Sadiq I, Athar H, Amed MH, Papaioannou GI, et al. The evolving management of in-stent restenosis in the drug eluting stent era. Am J Cardiol 2004;94(Suppl):219E.
  17. 2004 – Ahmed MH, Ahmed SU, Papaioannou GI, et al. Diabetes mellitus does not significantly impact percutaneous coronary outcomes in the current era of glycoprotein inhibitors and drug eluting stents. Am J Cardiol 2004;94(Suppl):100E.
  18. 2004 – Ahmed MH, Elkoustaf RA, Papaioannou GI, et al. Gender does not impact the percutaneous coronary intervention outcome for non ST-segment elevation acute coronary syndrome. Am J Cardiol 2004;94(Suppl):203E.
  19. 2004 – Papaioannou GI, Patel SB, Dada MR, et al. Renal insufficiency predicts adverse in-hospital outcomes in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. ESC Congress 2004:3028.
  20. 2004 – Papaioannou GI, Seip RL, Grey NJ, et al. Peripheral vascular endothelial function and myocardial perfusion imaging in asymptomatis type 2 diabetics. ESC Congress 2004:3021.
  21. 2004 – Papaioannou GI, Sadiq I, Ahmed MH, et al. A comparison of primary percutaneous intervention with and without adjunctive pharmacological reperfusion therapy in patients with acute ST-segment elevation myocardial infarction presenting in community hospitals. Catheter Cardiovasc Interv 2004;62:131.
  22. 2004 – Papaioannou GI, Ahmed MH, Sadiq I, et al. Facilitated percutaneous intervention is associated with improved in-hospital outcomes in patients with acute myocardial infarction complicated by cardiogenic shock. Catheter Cardiovasc Interv 2004;62:131.
  23. 2004 – Ahmed MH, Sadiq I, Papaioannou GI, et al. Percutaneous subclavian artery closure: A unique use of perclose. Catheter Cardiovasc Interv 2004;62:90.
  24. 2004 – Ahmed MH, Mather JF, Papaioannou GI, et al. Predictors of red blood cell transfusion following percutaneous coronary intervention. Catheter Cardiovasc Interv 2004;62:116.
  25. 2004 – Ahmed MH, Papaioannou GI, Sadiq I, et al. Anemia as a risk factor for chronic renal insufficiency in patients undergoing percutaneous intervention. Catheter Cardiovasc Interv 2004;62:118.
  26. 2004 – Ahmed MH, Ahmed SU, Sadiq I, Papaioannou GI, et al. Patent foramen ovale closure in off-label patients with a single neurological event. Catheter Cardiovasc Interv 2004;62:107.
  27. 2004 – Sadiq I, Papaioannou GI, Ahmed MH, et al. In-stent restenosis – Changing patterns of treatment in the drug-eluting stent era. Catheter Cardiovasc Interv 2004;62:123.
  28. 2004 – Sadiq I, Ahmed MH, Papaioannou GI, et al. Stent thrombosis and drug-eluting stents in acute myocardial infarction. Catheter Cardiovasc Interv 2004;62:126.
  29. 2003 – Papaioannou GI, Grey NJ, Seip RL, et al. Predictors of impaired vascular reactivity in asymptomatic type 2 diabetics. Diabetes 2003;52(Suppl. 1):A164.
  30. 2003 – Papaioannou GI, Grey NJ, Seip RL, et al. Endothelial dysfunction in asymptomatic type 2 diabetics with and without microalbuminuria. Diabetes 2003;52(Suppl. 1):A164.

 

  

Αναζήτηση